Genocea Biosciences GNCA
$ 0.05
-15.0%
Quarterly report 2022-Q1
added 12-23-2023
Country |
USA |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. William Clark |
Employees in the company |
59 |
Shares |
68.6 M |
Market Cap[1] |
$ 3.04 M |
EBITDA (LTM) |
$ -53.7 M |
P/E (LTM) |
-0.1 |
P/S (LTM) |
0.93 |
EPS (LTM) |
-0.51 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.